Healthy Extracts (Healthy Extracts) Risk Assessment

View and export this data going back to 2015. Start your Free Trial

What is Healthy Extracts Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Healthy Extracts is: High Risk: High uncertainty.

Competitive Comparison of Healthy Extracts's Risk Assessment

For the Drug Manufacturers - Specialty & Generic subindustry, Healthy Extracts's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Healthy Extracts's Risk Assessment Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Healthy Extracts's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Healthy Extracts's Risk Assessment falls into.

Healthy Extracts (OTCPK:HYEX) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Healthy Extracts Risk Assessment Related Terms

Thank you for viewing the detailed overview of Healthy Extracts's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Healthy Extracts (Healthy Extracts) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Healthy Extracts Inc (OTCPK:HYEX) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

7375 Commercial Way, Suite 125, Henderson, NV, USA, 89011

Website

https://www.healthyextractsinc.com

Healthy Extracts Inc through its subsidiaries is engaged in proprietary research and development of natural plant-based formulations, manufacturing, sales, and distribution of cardiovascular and neuro products that provide natural brain solutions. The company also provides superfruit supplements to support overall cholesterol and cardiovascular health. Its products are distributed in the United States and Mexico. The company's operating segment includes Health Supplements and Corporate. It generates maximum revenue from the Health Supplements segment.

Executives

Robert Michael Madden	officer: Chief Financial Officer	5269 SOUTH ALVERA CIR, SALT LAKE CITY UT 84117
Croyle William Russell Jr	director	1 SILVERMOUND, LITTLETON CO 80127
Kevin Pitts	10 percent owner, officer: President	3664 CHRISTY RIDGE RD., SEDALIA CO 80135
Sanjeevkumar Ratanshi Javia	director, officer: President	7161 E. RANCHO VISTA DRIVE, SUITE 3008, SCOTTSDALE AZ 85251
Patrick Stiles	director, 10 percent owner, officer: President, CEO	10300 W. CHARLESTON, LAS VEGAS NV 89135
Joseph Nejman	director, 10 percent owner, officer: President	555 BRYANT ST., SUITE 555, PALO ALTO CA 94301
William C Bossung	director, 10 percent owner, officer: CFO and Secretary	10300 W. CHARLESTON BLVD., STE. 13-378, LAS VEGAS NV 89135
Brian J Dunn	director, 10 percent owner	7075 FLYING CLOUD DRIVE, EDEN PRAIRIE MN 55344
Fred Covely	director, 10 percent owner, officer: President and CEO	1508 GRANDVIEW RD., VISTA CA 92084